Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

TMEM126B mutations cause severe isolated complex I deficiency with variable clinical phenotype

May 27, 2016

FDA advisory committee recommends approval of insulin glargine/lixisenatide

May 26, 2016

Eli Lilly introduces drug conjugates for bone disorders

May 26, 2016

Acad10 gene knockout mice are a potential model of diabetes

May 26, 2016

Monoclonal antibody targets gastric inhibitory polypeptide to treat obesity

May 26, 2016

FDA clears IND application for Abeona's ABO-101

May 25, 2016

FDA approves Janssen Pharmaceutical's Invokamet line extension

May 25, 2016

Eli Lilly initiates phase I trial of LY-3298176 for type 2 diabetes

May 25, 2016

Phase III trial results presented for alirocumab in Japan

May 24, 2016

FDA awards fast track designation for AEB-1102 in hyperargininemia

May 24, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...